Javascript must be enabled to continue!
Abstract 4358025: County-Level Social Disadvantage Independently Predicts Higher Risk-Adjusted Heart Failure Hospitalization Rates in the United States
View through CrossRef
Background:
Heart failure (HF) is a major cause of morbidity and hospitalization in the United States. Place-based social determinants of health, including community-level vulnerability and deprivation, influence cardiovascular disease prevalence, risk factors, and outcomes, but their association with heart failure hospitalizations (HFH) has not been extensively studied. We examined the relationship between county-level social disadvantage indices [Social Vulnerability Index (SVI) and the Social Deprivation Index (SDI)] and risk-adjusted HFH rates (RA-HFHR) in the US from 2020 to 2022.
Methods:
In this retrospective study, county-level RA-HFHR data for persons aged ≥18 years obtained from the Agency for Healthcare Research and Quality were linked to their corresponding 2022 SVI data (obtained from the CDC) and the 2019 SDI data (https://www.graham-center.org/maps-data-tools/social-deprivation-index.html). These indices are computed from sociodemographic factors from the American Community Survey. SVI and SDI scores were assigned percentile scores, with higher values indicating greater social disadvantage. The linked dataset was divided into four quartiles (1st quartile [Q1] and least vulnerable or deprived, and 4
th
quartile [Q4] and most vulnerable/deprived). RA-HFHR per 100,000 with 95% confidence intervals (CI) were computed for each quartile and then stratified by age (18-44, 45-64, ≥65 years) and gender. A negative impact by SVI or SDI was characterized by a higher RA-HFHR in Q4 than in Q1, with non-overlapping CI. Rate differences (excess or fewer hospitalizations per 100,000) were derived by obtaining the differences between Q4 and Q1.
Results:
A total of 1905 counties from 33 states (>70% of the US population) were included. For SVI, the RA-HFHR increased in a stepwise manner from Q1 221.6 (CI: 212.1-231.3) in Q1 to 390.9 (CI: 77.9-404.3) in Q4, with an excess of 169.3 in Q4. The trend was similar in both genders and across all age groups (Table 1). Similarly, for SDI, the RA-HFHR significantly and progressively from 220.7 (CI: 212.2-228.9) in Q1 to 408.9 (CI: 393.9-423.4) in Q4, yielding an excess of 188.2 in Q4. Again, the trend was similar in both genders and across all age groups (Table 2).
Conclusion:
Counties with higher social vulnerability and deprivation are associated with higher RA-HFHRs. The inclusion of these indices in risk prediction models could help identify patients with HF at high risk of getting hospitalized.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 4358025: County-Level Social Disadvantage Independently Predicts Higher Risk-Adjusted Heart Failure Hospitalization Rates in the United States
Description:
Background:
Heart failure (HF) is a major cause of morbidity and hospitalization in the United States.
Place-based social determinants of health, including community-level vulnerability and deprivation, influence cardiovascular disease prevalence, risk factors, and outcomes, but their association with heart failure hospitalizations (HFH) has not been extensively studied.
We examined the relationship between county-level social disadvantage indices [Social Vulnerability Index (SVI) and the Social Deprivation Index (SDI)] and risk-adjusted HFH rates (RA-HFHR) in the US from 2020 to 2022.
Methods:
In this retrospective study, county-level RA-HFHR data for persons aged ≥18 years obtained from the Agency for Healthcare Research and Quality were linked to their corresponding 2022 SVI data (obtained from the CDC) and the 2019 SDI data (https://www.
graham-center.
org/maps-data-tools/social-deprivation-index.
html).
These indices are computed from sociodemographic factors from the American Community Survey.
SVI and SDI scores were assigned percentile scores, with higher values indicating greater social disadvantage.
The linked dataset was divided into four quartiles (1st quartile [Q1] and least vulnerable or deprived, and 4
th
quartile [Q4] and most vulnerable/deprived).
RA-HFHR per 100,000 with 95% confidence intervals (CI) were computed for each quartile and then stratified by age (18-44, 45-64, ≥65 years) and gender.
A negative impact by SVI or SDI was characterized by a higher RA-HFHR in Q4 than in Q1, with non-overlapping CI.
Rate differences (excess or fewer hospitalizations per 100,000) were derived by obtaining the differences between Q4 and Q1.
Results:
A total of 1905 counties from 33 states (>70% of the US population) were included.
For SVI, the RA-HFHR increased in a stepwise manner from Q1 221.
6 (CI: 212.
1-231.
3) in Q1 to 390.
9 (CI: 77.
9-404.
3) in Q4, with an excess of 169.
3 in Q4.
The trend was similar in both genders and across all age groups (Table 1).
Similarly, for SDI, the RA-HFHR significantly and progressively from 220.
7 (CI: 212.
2-228.
9) in Q1 to 408.
9 (CI: 393.
9-423.
4) in Q4, yielding an excess of 188.
2 in Q4.
Again, the trend was similar in both genders and across all age groups (Table 2).
Conclusion:
Counties with higher social vulnerability and deprivation are associated with higher RA-HFHRs.
The inclusion of these indices in risk prediction models could help identify patients with HF at high risk of getting hospitalized.
Related Results
Assessing variance in inpatient hospitalization rates for three major chronic conditions
Assessing variance in inpatient hospitalization rates for three major chronic conditions
Introduction: A chronic condition is broadly defined as a health condition lasting one or more years that requires relatively consistent medical attention and/or imposes limitation...
Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study
Treatment outcomes and associated factors among chronic ambulatory heart failure patients at Jimma Medical Center, South West Ethiopia: prospective observational study
Abstract
Background
Heart failure has been one of the major causes of hospitalization across the world. Focusing on the treatment outcomes of ambula...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...
Assessing survival time of heart failure patients: using Bayesian approach
Assessing survival time of heart failure patients: using Bayesian approach
AbstractHeart failure is a failure of the heart to pump blood with normal efficiency and a globally growing public health issue with a high death rate all over the world, including...
PROGNOSTIC VALUE OF CIRCULATING CATESTATIN LEVELS ON HOSPITALISED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
PROGNOSTIC VALUE OF CIRCULATING CATESTATIN LEVELS ON HOSPITALISED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Objectives
To evaluate prognostic value of circulating catestatin (CST) on hospitalised patients with acute myocardial infarction.
...

